Answers are grounded in this paper and cite their sources.
Sjogren's syndrome (SS) is a complex heterogeneous autoimmune disease resulting in loss of salivary gland and lacrimal gland function that may include multiple systemic manifestations including lymphoma. Multiple cell types participate in disease pathogenesis. This review discusses evidence for abnormal B cell subpopulations in patients with SS, critical roles of B cells in SS and the status of B cell-directed therapies in the management of patients with SS.
No takes yet. Share an insight, caveat, or question.
Ambrus et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: